HRP20100504T1 - 2-(4-cijanofenil)-6-hidroksilaminopirimidini koji inhibiraju hiv - Google Patents

2-(4-cijanofenil)-6-hidroksilaminopirimidini koji inhibiraju hiv Download PDF

Info

Publication number
HRP20100504T1
HRP20100504T1 HR20100504T HRP20100504T HRP20100504T1 HR P20100504 T1 HRP20100504 T1 HR P20100504T1 HR 20100504 T HR20100504 T HR 20100504T HR P20100504 T HRP20100504 T HR P20100504T HR P20100504 T1 HRP20100504 T1 HR P20100504T1
Authority
HR
Croatia
Prior art keywords
compound according
pharmaceutically acceptable
compounds
formula
bromo
Prior art date
Application number
HR20100504T
Other languages
English (en)
Croatian (hr)
Inventor
Augustinus De Kock Herman
Piet Tom Bert Paul Wigerinck Piet
Original Assignee
Tibotec Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharmaceuticals filed Critical Tibotec Pharmaceuticals
Publication of HRP20100504T1 publication Critical patent/HRP20100504T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20100504T 2005-03-04 2010-09-13 2-(4-cijanofenil)-6-hidroksilaminopirimidini koji inhibiraju hiv HRP20100504T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05101707 2005-03-04
PCT/EP2006/060407 WO2006094930A1 (en) 2005-03-04 2006-03-02 Hiv inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines

Publications (1)

Publication Number Publication Date
HRP20100504T1 true HRP20100504T1 (hr) 2010-10-31

Family

ID=34938904

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100504T HRP20100504T1 (hr) 2005-03-04 2010-09-13 2-(4-cijanofenil)-6-hidroksilaminopirimidini koji inhibiraju hiv

Country Status (20)

Country Link
US (2) US20080214588A1 (el)
EP (1) EP1858861B1 (el)
JP (1) JP5118978B2 (el)
CN (1) CN101133038B (el)
AT (1) ATE473212T1 (el)
AU (1) AU2006222057B2 (el)
BR (1) BRPI0609291B1 (el)
CY (1) CY1111102T1 (el)
DE (1) DE602006015291D1 (el)
DK (1) DK1858861T3 (el)
ES (1) ES2347815T3 (el)
HR (1) HRP20100504T1 (el)
ME (1) ME01229B (el)
MX (1) MX2007010744A (el)
PL (1) PL1858861T3 (el)
PT (1) PT1858861E (el)
RS (1) RS51435B (el)
RU (1) RU2401261C2 (el)
SI (1) SI1858861T1 (el)
WO (1) WO2006094930A1 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007010051A (es) * 2005-02-18 2007-09-21 Tibotec Pharm Ltd Derivados de oxido de 2-(4-cianofenilamino)pirimidina que inhiben el virus de inmunodeficiencia humana.
WO2008071587A2 (en) 2006-12-13 2008-06-19 F. Hoffmann-La Roche Ag 2-(piperidin-4-yl)-4-phenoxy- or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors
UA106972C2 (uk) * 2009-06-22 2014-11-10 Емк'Юр Фармас'Ютікалз Лімітед Спосіб синтезу діарилпіримідинового ненуклеозидного інгібітора зворотної транскриптази
US8153790B2 (en) 2009-07-27 2012-04-10 Krizmanic Irena Process for the preparation and purification of etravirine and intermediates thereof
CN101993419B (zh) * 2009-08-20 2013-01-16 浙江九洲药业股份有限公司 一种4-[(5-溴-4,6-二氯-2-嘧啶基)氨基]苯甲腈的制备方法
GR1007010B (el) 2009-10-08 2010-10-07 Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), Ινσουλινοειδη πεπτιδια
WO2011135578A1 (en) 2010-04-28 2011-11-03 Chetan Balar Composition comprising chitin and tinosporin for use in the treatment of viral diseases
WO2013059572A1 (en) 2011-10-19 2013-04-25 Assia Chemical Industries Ltd. Process for the preparation of etravirine and intermediates in the synthesis thereof
CU20220045A7 (es) 2020-02-19 2023-03-07 Pharmasyntez Compuestos derivados sustituidos de pirimidina para el tratamiento y prevención de la infección por vih

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) * 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
EP0862463A1 (en) 1995-11-23 1998-09-09 Janssen Pharmaceutica N.V. Solid mixtures of cyclodextrins prepared via melt-extrusion
OA11674A (en) * 1998-11-10 2005-01-12 Janssen Pharmaceutica Nv HIV Replication inhibiting pyrimidines.
EA005423B1 (ru) * 1999-09-24 2005-02-24 Янссен Фармацевтика Н.В. Противовирусные композиции
AU782948B2 (en) * 2000-05-08 2005-09-15 Janssen Pharmaceutica N.V. Prodrugs of HIV replication inhibiting pyrimidines

Also Published As

Publication number Publication date
AU2006222057B2 (en) 2012-10-04
SI1858861T1 (sl) 2010-10-29
CN101133038B (zh) 2012-06-27
PL1858861T3 (pl) 2010-12-31
CN101133038A (zh) 2008-02-27
ATE473212T1 (de) 2010-07-15
RU2007136782A (ru) 2009-04-10
EP1858861A1 (en) 2007-11-28
BRPI0609291B1 (pt) 2022-02-08
DK1858861T3 (da) 2010-11-08
MX2007010744A (es) 2007-09-12
CY1111102T1 (el) 2015-06-11
ES2347815T3 (es) 2010-11-04
WO2006094930A1 (en) 2006-09-14
RS51435B (en) 2011-04-30
US8119801B2 (en) 2012-02-21
JP2008531658A (ja) 2008-08-14
PT1858861E (pt) 2010-09-16
US20100121060A1 (en) 2010-05-13
EP1858861B1 (en) 2010-07-07
RU2401261C2 (ru) 2010-10-10
ME01229B (me) 2013-06-20
US20080214588A1 (en) 2008-09-04
BRPI0609291A2 (pt) 2010-03-09
JP5118978B2 (ja) 2013-01-16
AU2006222057A1 (en) 2006-09-14
DE602006015291D1 (de) 2010-08-19

Similar Documents

Publication Publication Date Title
HRP20100504T1 (hr) 2-(4-cijanofenil)-6-hidroksilaminopirimidini koji inhibiraju hiv
HRP20090459T1 (hr) Aminofenil derivati kao novi inhibitori histonskih deacetilaza
ME00131B (me) Derivati hinolina i njihova upotreba kao mikobakterijskih inhibitora
HRP20160967T1 (hr) Heterociklički spojevi korisni kao pdk1 inhibitori
NZ594589A (en) 3h-imidazo [4, 5 -c] pyridine- 6 -carboxamides as anti- inflammatory agents
HRP20140011T1 (hr) Derivati oksazina i njihova uporaba u lijeäśenju neuroloških poremeä†aja
NO20081325L (no) Nye doseringsformuleringer
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
EA200602260A1 (ru) Применение замещенных хинолиновых производных для лечения заболеваний, вызываемых микобактериями, резистентными к лекарственным средствам
BR0207872A (pt) Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração
WO2006117211A3 (en) Urea derivatives methods for their manufacture and uses thereof
MA38854A1 (fr) Dérivés amides utilisés en tant qu'antagonistes des récepteurs de l'acide lysophosphatidique
PH12020552236A1 (en) Crystal form of compound for inhibiting the activity of cdk4/6 and use thereof
EA200800455A1 (ru) Антибактериальные производные хинолина
CA2573315A1 (en) Benzoic acid derivatives as non-nucleoside reverse transcriptase inhibitors
BRPI0519152A2 (pt) composto ou um sal ou derivado Éster farmaceuticamente aceitÁvel do mesmo, formulaÇço farmacÊutica, formulaÇÕes para tratar osteoporose e psorÍase, uso de um composto ou de um sal farmaceuticamente aceitÁvel do mesmo, e, composiÇço farmacÊutica
WO2009049648A3 (en) Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof
EE9900591A (et) Tiadiasolüülpüridasiini derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
HRP20120499T1 (hr) Fumarat cijanoetenil dimetilfenil amino pirimidinil amino benzonitrila
JP2012524812A5 (el)
PL429245A1 (pl) Sposób otrzymywania 2-hydroksypropanosulfonianów [(3-alkanoilo metyloamino)propylo] dimetyloamoniowych
TH78309B (th) สารยับยั้งมายคอแบคทีเรียชนิดใหม่
TH130492A (th) 5-อะมิโน-4-ไฮดรอกซีเพนโทอิลเอไมด์
ITMI20032020A1 (it) Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici
TH142783A (th) การตั้งสูตรตำรับยาทาภายนอกและวิธีการใช้